India has world renowned capacity in producing low cost, high quality bulk and generic drugs. Supply of such drugs and investment in producing pharmaceutical products in Belarus through JV by Indian companies will provide win-win situation for both countries. Presently $ 700 million is the size of pharma market in Belarus and about 70 percent of the total requirement of Belarus is imported. Thus it will also help fulfill Belarus` target of domestic production of 50 percent of all drugs required.
The US-based Indian Pharma company, SOHM, Inc., that manufactures and markets generic pharmaceuticals, nutraceutical and dermatology has launched additional product lines that include: Dry dermatoses, mixed skin infection, acne vulgaris, seborrhic dermatitis, and cuts, wounds and burns products.
Mumbai based mid- sized Indian Pharma company, Aanjaneya Lifecare Limited, is planning expansion in the domestic and international market.
The US subsidiary of Lupin Limited, Lupin Pharmaceuticals, Inc. (LPI) has received tentative approval for its metformin hydrochloride extended release tablets (HCl ER) 500 mg and 1000 rug from the United States Food and Drugs Administration (FDA).
After Ranbaxy Labs and Piramal Healthcare, another billion-dollar-plus deal might be in the works in the Indian pharmaceutical space. Israel’s Teva Pharmaceutical Industries Ltd, the world’s largest generic drug-maker, and Pfizer, the world’s biggest pharmaceutical company, as well as other private equity buyout firms, are eyeing Bangalore-based privately held Micro Labs Ltd, VCCircle has reported.
Indian Board of Alternative Medicines (IBAM) has been granted accreditation by the American Association of Drugless Practitioners (AADP), a professional association that offers professional accreditation in naturopathy and other areas of natural health in the United States of America and around the world.
Aptar Pharma world leader in the development and manufacturing of nasal and pulmonary drug delivery devices has opened a new facility at Rabale, Navi Mumbai.
Do to Growth Hormone Deficiency disorder, children get psychological stress, which makes them inactive than the normal growth children, says Dr Jayashree Gopal, Senior Consultant Endocrinologist and Diabetologist, Apollo Hospitals in Chennai.
The Bangalore-based Strides Arcolab has sold its Australian unit, Ascent Pharmahealth, to Watson Pharmaceuticals for a consideration of US$393 million . The deal is expected to reduce the debt of Strides by almost half (by US$250 million). This deal will make Watson Australia’s fifth largest generic pharmaceutical company based on revenue, media reports say.
Sotax India and Pharma Edge Centre will be organizing a three-day workshop on in vitro-in vivo correlation (IVIVC) in Mumbai from January 27 to 29, 2012.
One of India's leading pharmaceutical firms, Lupin announced yesterday that its consolidated net profit surged 4.95 percent to Rs 235 crore in the quarter ended December 31, 2011 thanks to the healthy sales in the overseas markets including the US, India and Japan.
Indian pharmaceutical industry’s adherence to good manufacturing practice (GMP) would help it become a global outsourcing hub for manufacturing. The sector has emerged as one of the world's leading and fastest growing markets which spells excellence in manufacturing
Sohm, a generic pharmaceutical manufacturer, has started production of neutraceutical product line, including Diorac, a unique probiotic anti-diarrheal product, at its new neutraceutical manufacturing facility in Ahmedabad.
The Ahmedabad-based Dishman Pharmaceuticals & Chemicals is planning to sell its Chinese factory, at the Shanghai Chemical Industry Park, for an expected return of $25 million. The proceeds from the possible sale, likely by June 2012, would be used to reduce debt, the company sources said in Bangalore.
Dr Mayilvahanan Natarajan, Vice Chancellor of the Tamilnadu MGR Medical University formally inaugurated the first national conference on 'Simulation in Health Care' in Chennai yesterday.
